Windward Bio: Omega funds buy 1.75M shares at $17
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Windward Bio Group AG director Otello Stampacchia reported transactions involving Omega Fund VII, L.P. and Omega Fund VIII, L.P.: each fund purchased 875,000 common shares at $17.00 per share on November 16, 2026. The funds’ Series A and Series B preferred shares converted automatically into 3,588,520 common shares on a 1-to-1 basis immediately before the initial public offering closed. The preferred shares had no expiration date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series A Preferred Shares F3, F1 | 1,262,628 | $0.00 | $0.00 |
| Conversion | Series A Preferred Shares F3, F2 | 1,262,626 | $0.00 | $0.00 |
| Conversion | Series B Preferred Shares F3, F1 | 531,632 | $0.00 | $0.00 |
| Conversion | Series B Preferred Shares F3, F2 | 531,634 | $0.00 | $0.00 |
| Purchase | Common Shares F1 | 875,000 | $17.00 | $14.88M |
| Purchase | Common Shares F2 | 875,000 | $17.00 | $14.88M |
| Conversion | Common Shares F3, F1 | 1,262,628 | -- | -- |
| Conversion | Common Shares F3, F2 | 1,262,626 | -- | -- |
| Conversion | Common Shares F3, F1 | 531,632 | -- | -- |
| Conversion | Common Shares F3, F2 | 531,634 | -- | -- |
Footnotes (3)
- F1. Shares held directly by Omega Fund VII, L.P. ("Omega VII"). Omega Fund VII GP, L.P. ("Omega VII GP") is the sole general partner of Omega VII. Omega Fund VII GP Manager, Ltd. ("Omega VII Manager") is the sole general partner of Omega VII GP. The Reporting Person, Claudio Nessi and Francesco Draetta are the directors of Omega VII Manager and each disclaims beneficial ownership of the shares held by Omega VII except to the extent of his pecuniary interest therein, if any.
- F2. Shares held directly by Omega Fund VIII, L.P. ("Omega VIII"). Omega Fund VIII GP, L.P. ("Omega VIII GP") is the sole general partner of Omega VIII. Omega Fund VIII GP Manager, Ltd. ("Omega VIII Manager") is the sole general partner of Omega VIII GP. The Reporting Person, Claudio Nessi and Francesco Draetta are the directors of Omega VIII Manager and each disclaims beneficial ownership of the shares held by Omega VIII except to the extent of his pecuniary interest therein, if any.
- F3. Each Series A Preferred Share and Series B Preferred Share automatically converted into the number of Common Shares on a 1 to 1 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
Key Figures
Key Terms
initial public offering financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.